Guminski, A.; Squittieri, N.; Lear, J. T. Adverse Events of Special Interest in Patients With Advanced Basal Cell Carcinoma Receiving Sonidegib: Long-Term 42-Month Results from the BOLT Study. J of Skin 2020, 4, s67.